ALFA Filings
Every announcement, straight from the exchange
Every Morepen Laboratories business update announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements
Morepen Laboratories submitted its first Abbreviated New Drug Application (ANDA) to the U.S. FDA for Sitagliptin Tablets USP, marking a significant milestone in its integrated CDMO capabilities.
Morepen Laboratories started commercial supplies under an ₹825 Crore CDMO mandate. The first dispatch of ₹50 Crore was completed in Q1FY2026-27.
Morepen Laboratories revised the 'Appointed Date' for its internal business transfer to subsidiary Morepen Medipath to April 1, 2026. The delay allows time for statutory and regulatory approvals.